Fundies.
English

APPLIED DNA SCIENCES INC

EDGAR
APDN Quarterly report (10-Q) · filed 2026-08-13

270 filing records in this dataset, filed from 1998-03-06 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

884 thousand USD

2019 Q1 · USD

Exact inputs and evidence
Cash and cash equivalents
3.76 million Unit_Standard_USD_ITsArzQd-0GJeWhyKsgkjA Source
Exact value

3761482 Unit_Standard_USD_ITsArzQd-0GJeWhyKsgkjA

Long-term debt including current maturities
Not available
Shares outstanding
6.2 million Unit_Standard_shares_KO5dkj7e8k2bG2aG5R4gAA Source
Exact value

6197223 Unit_Standard_shares_KO5dkj7e8k2bG2aG5R4gAA

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-09-30.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2019-09-30
  • Operating income: 2 of 11 periods available· newest 2025-09-30
  • Net income: 2 of 11 periods available· newest 2025-09-30
  • Operating cash flow: 2 of 11 periods available· newest 2025-09-30
  • Capital expenditure: 2 of 11 periods available· newest 2025-09-30
  • Total assets: Multiple units; comparison withheld· newest 2025-09-30
  • Total liabilities: Multiple units; comparison withheld· newest 2025-09-30
  • Current assets: Multiple units; comparison withheld· newest 2025-09-30
  • Current liabilities: Multiple units; comparison withheld· newest 2025-09-30
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-09-30
  • long term debt: No compatible figures in this window
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 8.17 million

    Prior period

    −Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 6.99 million

    –

    Current period

    −Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 15.16 million

    –

    Exact inputs and evidence

    -15160724 − -6992521 = -8168203 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

    -6992521 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -15160724 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 1.35 million

    Prior period

    −Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 13.59 million

    –

    Current period

    −Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 12.24 million

    –

    Exact inputs and evidence

    -12242654 − -13590228 = 1347574 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

    -13590228 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -12242654 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -23.2%

    Prior period

    Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 407,904

    –

    Current period

    Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 313,121

    –

    Exact inputs and evidence

    313121 − 407904 = -94783 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

    407904 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    313121 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2018-10-01 – 2019-09-30

  • Revenue Unit12 5.39 million 100% of revenue
  • Operating costs Derived Unavailable An input is unavailable.
  • Operating income Unavailable An input is unavailable.
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income Unavailable An input is unavailable.

Cash

  • Operating cash flow Unavailable An input is unavailable.
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2018-10-01 – 2019-09-305389089 UnavailableUnavailableUnavailableUnavailableUnavailable
Source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 5.4M 2019
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.8M4.4M2.9M1.5M0.02019
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2019Revenue5389089

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019-09-30Operating marginNot reported
2019-09-30Net marginNot reported
2019Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2019Operating cash flowNot reportedNo source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValueSource evidence
2019Free cash flowUnavailableNo source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019-09-30Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019-09-30Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2023-10-01 – 2024-09-30
−Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 6.99 million
Exact value

Exact value: -6992521 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

2023-10-01 – 2024-09-30: -6992521 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 13.59 million
Exact value

Exact value: -13590228 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

2023-10-01 – 2024-09-30: -13590228 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 407,904
Exact value

Exact value: 407904 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

2023-10-01 – 2024-09-30: 407904 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 14 million
Calculation and evidence

-13590228 − 407904 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

Exact free cash flow: -13998132 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2024-10-01 – 2025-09-30
−Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 15.16 million
Exact value

Exact value: -15160724 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

2024-10-01 – 2025-09-30: -15160724 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 12.24 million
Exact value

Exact value: -12242654 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

2024-10-01 – 2025-09-30: -12242654 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 313,121
Exact value

Exact value: 313121 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

2024-10-01 – 2025-09-30: 313121 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg 12.56 million
Calculation and evidence

-12242654 − 313121 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

Exact free cash flow: -12555775 Unit_Standard_USD_qmay4yPadUSBF-belY8_Cg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

270 filings · 5,760 latest values · 5,760 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000744452, 744452, APDN, BNBX, apdn, edgar:744452

Also known as APPLIED DNA SCIENCES INC, APPLIED DNA SCIENCES INC., APPLIED DNA SCIENCES, INC., Applied DNA Sciences, Inc., BNB PLUS CORP., BNB Plus Corp., DATALINK CAPITAL CORP/TX/, DCC ACQUISITION CORP, PROHEALTH MEDICAL TECHNOLOGIES INC